Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000225585 | SCV000822642 | uncertain significance | Autosomal dominant Parkinson disease 8 | 2024-10-27 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 286 of the LRRK2 protein (p.Leu286Val). This variant is present in population databases (rs200437744, gnomAD 0.05%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with clinical features of Parkinson disease (PMID: 24082139, 26213354). ClinVar contains an entry for this variant (Variation ID: 236286). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on LRRK2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Athena Diagnostics | RCV001658050 | SCV001880905 | likely benign | not specified | 2020-11-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000225585 | SCV000282476 | uncertain significance | Autosomal dominant Parkinson disease 8 | 2014-12-11 | no assertion criteria provided | literature only |